ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print May 17, 2006, 10.1183/09031936.06.00092205
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sørhaug, S.
Right arrow Articles by Steinshamn, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sørhaug, S.
Right arrow Articles by Steinshamn, S.
Eur Respir J 2006; 28:542-548
Copyright ©ERS Journals Ltd 2006

Increased serum levels of chromogranin A in male smokers with airway obstruction

S. Sørhaug1,2, A. Langhammer3, H. L. Waldum4,5, K. Hveem3 and S. Steinshamn1,2

1 Depts of Circulation and Medical Imaging, and, 4 Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, and, Depts of 2 Pulmonary Medicine, and, 5 Medicine, Section of Gastroenterology, St. Olavs Hospital, Trondheim, 3 HUNT Research Centre, Norwegian University of Science and Technology, Verdal, Norway.

CORRESPONDENCE: S. Sørhaug, Dept of Pulmonary Medicine, St. Olavs Hospital, N-7006 Trondheim, Norway. Fax: 47 73867424. E-mail: sveinung.sorhaug{at}ntnu.no

Keywords: Airway obstruction, chromogranin A, lung function, neuroendocrine system, sex, smoking

Received: August 9, 2005
Accepted April 22, 2006

The neuroendocrine (NE) system may play an important role in smoking-induced airway diseases. The aim of the present study was to examine the relationship between serum levels of the general NE marker chromogranin A (CgA) and smoking habits, respiratory symptoms and lung function.

The study population consisted of never-smokers with normal lung function, smokers with normal lung function and smokers with airway obstruction who were randomly selected from the lung study of the Nord-Trøndelag Health Study (HUNT). Serum CgA was determined in 151, 138 and 116 subjects, respectively. All subjects were seronegative for Helicobacter pylori.

Male smokers with airway obstruction had significantly higher serum CgA levels (median 3.70 nmol·L-1 (interquartile range 3.10–5.15)) than both smokers with normal lung function (3.00 nmol·L-1 (2.50–3.67)) and never-smokers with normal lung function (2.90 nmol·L-1 (2.57–3.30)). The elevated levels of CgA correlated with the degree of airway obstruction. Moreover, the presence of respiratory symptoms and chronic bronchitis among male smokers were associated with increased serum CgA levels. Females had CgA levels similar to male smokers independent of smoking status and lung function.

Elevated serum chromogranin A levels in subjects with airway obstruction and respiratory symptoms may represent neuroendocrine activation in inflammatory or remodelling processes in the lung.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.